Association of Nationwide Hepatitis B Vaccination and Antiviral Therapy Programs With End-Stage Liver Disease Burden in Taiwan
Journal
JAMA network open
Journal Volume
5
Journal Issue
7
Pages
E2222367
Date Issued
2022-07-01
Author(s)
Jhuang, Jing-Rong
Yang, Ya-Wen
Zhuang, Bo-Zhi
You, San-Lin
Chen, Chien-Jen
Abstract
Chronic infections of hepatitis B and C viruses are the main causes of end-stage liver disease (ESLD) worldwide. The successful control of viral hepatitis is critical to reducing the burden of ESLD.
Subjects
HEPATOCELLULAR-CARCINOMA; VIRUS-INFECTION; AGE-PERIOD; TEMPORAL VARIATION; MORTALITY TRENDS; SECULAR TRENDS; CANCER RATES; RISK-FACTORS; TRANSMISSION; PREVALENCE
Publisher
AMER MEDICAL ASSOC
Type
journal article